Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials

BACKGROUND. Early phase clinical trials evaluate the safety and efficacy of new treatments. The exclusion/inclusion criteria in these trials are usually rigorous and may exclude many patients seen in clinical practice. Our objective was to study the comorbidities limiting the participation of patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Duma, Narjust, Kothadia, Sejal M., Azam, Tariq U., Yadav, Siddhartha, Paludo, Jonas, Vera Aguilera, Jesus, Gonzalez Velez, Miguel, Halfdanarson, Thorvardur Ragnar, Molina, Julian R., Hubbard, Joleen M., Go, Ronald S., Mansfield, Aaron S., Adjei, Alex A.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2018
Assuntos:
New Drug Development and Clinical Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6324635/
https://ncbi.nlm.nih.gov/pubmed/30413668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0687
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados